452 related articles for article (PubMed ID: 30488368)
21. Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.
García-Castillo M; García-Fernández S; Gómez-Gil R; Pitart C; Oviaño M; Gracia-Ahufinger I; Díaz-Regañón J; Tato M; Cantón R;
Int J Antimicrob Agents; 2018 Mar; 51(3):511-515. PubMed ID: 29371104
[TBL] [Abstract][Full Text] [Related]
22. Clearance of carbapenemase-producing Enterobacteriaceae (CPE) carriage: a comparative study of NDM-1 and KPC CPE.
Lim YJ; Park HY; Lee JY; Kwak SH; Kim MN; Sung H; Kim SH; Choi SH
Clin Microbiol Infect; 2018 Oct; 24(10):1104.e5-1104.e8. PubMed ID: 29870856
[TBL] [Abstract][Full Text] [Related]
23. [Carbapenemase producing Enterobacteriaceae in the Netherlands: unnoticed spread to several regions].
Leenstra T; Bosch T; Vlek AL; Bonten MJM; van der Lubben IM; de Greeff SC
Ned Tijdschr Geneeskd; 2017; 161():D1585. PubMed ID: 29076442
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors for Intra-Abdominal Infections Caused by Carbapenemase-Producing
Mora-Guzmán I; Rubio-Perez I; Domingo-Garcia D; Martin-Perez E
Surg Infect (Larchmt); 2021 Oct; 22(8):864-870. PubMed ID: 33857380
[No Abstract] [Full Text] [Related]
25. IMP-6 Carbapenemase-Producing Enterobacteriaceae Bacteremia Successfully Treated with Amikacin-Meropenem in Two Patients.
Nakakura I; Ogawa Y; Sakakura K; Imanishi K; Hirota K; Shimatani Y; Uehira T; Nakamori S; Sako R; Doi T; Yamazaki K
Pharmacotherapy; 2017 Oct; 37(10):e96-e102. PubMed ID: 28699652
[TBL] [Abstract][Full Text] [Related]
26. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
[TBL] [Abstract][Full Text] [Related]
27. Rapid detection of carbapenemase-producing Acinetobacter baumannii and carbapenem-resistant Enterobacteriaceae using a bioluminescence-based phenotypic method.
van Almsick V; Ghebremedhin B; Pfennigwerth N; Ahmad-Nejad P
J Microbiol Methods; 2018 Apr; 147():20-25. PubMed ID: 29427687
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
Zhang Y; Kashikar A; Bush K
J Antimicrob Chemother; 2017 Oct; 72(10):2792-2795. PubMed ID: 29091224
[TBL] [Abstract][Full Text] [Related]
29. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
[TBL] [Abstract][Full Text] [Related]
30. Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015.
Huang TD; Bogaerts P; Berhin C; Hoebeke M; Bauraing C; Glupczynski Y;
Euro Surveill; 2017 May; 22(19):. PubMed ID: 28537547
[TBL] [Abstract][Full Text] [Related]
31. Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures.
Trepanier P; Mallard K; Meunier D; Pike R; Brown D; Ashby JP; Donaldson H; Awad-El-Kariem FM; Balakrishnan I; Cubbon M; Chadwick PR; Doughton M; Doughton R; Hardiman F; Harvey G; Horner C; Lee J; Lewis J; Loughrey A; Manuel R; Parsons H; Perry JD; Vanstone G; White G; Shetty N; Coia J; Wiuff C; Hopkins KL; Woodford N
J Antimicrob Chemother; 2017 Feb; 72(2):596-603. PubMed ID: 27687074
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology, risk factors, and prediction score of carbapenem resistance among inpatients colonized or infected with 3rd generation cephalosporin resistant Enterobacterales.
Moghnieh R; Abdallah D; Jadayel M; Zorkot W; El Masri H; Dib MJ; Omar T; Sinno L; Lakkis R; Jisr T
Sci Rep; 2021 Jul; 11(1):14757. PubMed ID: 34285312
[TBL] [Abstract][Full Text] [Related]
34. The Likelihood of Developing a Carbapenem-Resistant
Tamma PD; Kazmi A; Bergman Y; Goodman KE; Ekunseitan E; Amoah J; Simner PJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138574
[TBL] [Abstract][Full Text] [Related]
35. Blood-Modified Carbapenem Inactivation Method: a Phenotypic Method for Detecting Carbapenemase-Producing
Sfeir MM; Satlin MJ; Fauntleroy KA; Jenkins SG; Westblade LF
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748319
[TBL] [Abstract][Full Text] [Related]
36. Carbapenem-resistant Enterobacteriaceae in wildlife, food-producing, and companion animals: a systematic review.
Köck R; Daniels-Haardt I; Becker K; Mellmann A; Friedrich AW; Mevius D; Schwarz S; Jurke A
Clin Microbiol Infect; 2018 Dec; 24(12):1241-1250. PubMed ID: 29654871
[TBL] [Abstract][Full Text] [Related]
37. Carbapenemase-producing Enterobacteriaceae isolates resistant to last-line antibiotics in an Italian general hospital.
Ferranti M; Schiaroli E; Palmieri MI; Repetto A; Vecchiarelli A; Francisci D; Mencacci A; Monari C
New Microbiol; 2018 Oct; 41(4):274-281. PubMed ID: 30252925
[TBL] [Abstract][Full Text] [Related]
38. Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study.
Tang SSL; Chee E; Teo JQ; Chlebicki MP; Kwa ALH
Int J Antimicrob Agents; 2021 Jun; 57(6):106340. PubMed ID: 33857538
[TBL] [Abstract][Full Text] [Related]
39. Epidemiological, clinical, and microbiological characteristics of carbapenemase-producing Enterobacteriaceae bloodstream infection in the Republic of Korea.
Park JW; Lee H; Park SY; Kim TH
Antimicrob Resist Infect Control; 2019; 8():48. PubMed ID: 30873279
[TBL] [Abstract][Full Text] [Related]
40. Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia.
Hovan MR; Narayanan N; Cedarbaum V; Bhowmick T; Kirn TJ
Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115505. PubMed ID: 34399381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
